Sample menu:

Macedonian Veterinary Review

logo

p-ISSN 1409-7621
e-ISSN 1857-7415

line
Co-publishing with:
line
 
De Gruyter
line
Membership
line
cope
line
crossref
line
linked
line
crosref1
line
ithenticate
line
 

Abstract / References


Linija
Origibal Scientific Article
 
access
 

Vascular endothelial growth factor (VEGF) in abdominal fluid in dogs with oncological and non-oncological diseases
Tsanko Hristov
Department of Internal Non-Infectious Diseases, Faculty of Veterinary Medicine, Trakia University, Stara Zagora 6000, Bulgaria

 

ABSTRACT
The vascular endothelial growth factor (VEGF) is a multifunctional cytokine stimulating the growth of vascular endothelial cells, survival and proliferation, inhibiting apoptosis. It is one of the most potent stimulants of vascular permeability. VEGF is found at high levels in inflammatory and tumour-associated pleural and abdominal effusions and is involved in their occurrence. In the present study, the blood plasma and abdominal fluid VEGF levels were assayed in thirty-one client-owned dogs with neoplastic and non-neoplastic diseases by means of enzyme-linked immunosorbent assay (ELISA). The VEGF concentration in abdominal fluid of dogs (n=6) with ascites was 190.70±34.35 pg/ml, in dogs (n=6) with peritonitis: 1449.81±365.42 pg/ml and in dogs (n=9) with tumour-associated effusion: 1993.13±202.56 pg/ml. Blood plasma VEGF of healthy dogs (control group, n=10) was 36.79±5.72 pg/ml, in dogs with ascites: 57.92±2.88 pg/ml, in dogs with peritonitis: 76.98±7.24 pg/ml and in dogs with tumour-associated effusion: 173.50±40.9 pg/ml. There were substantial differences between blood plasma and abdominal fluid VEGF levels.
Key words: vascular endothelial growth factor, abdominal fluid, tumours, dogs

Mac Vet Rev 2019; 42 (2): i-vi
   
[ PDF Free Article ] pdf Linija          
Available Online First:31 August 2019
 
 
Linija
References
 
 
 

    1. Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25(4): 581-611.
    https://doi.org/10.1210/er.2003-0027
    PMid:15294883

    2. Pidgeon, GP., Barr, MP., Harmey, JH., Foley, DA., Bouchier-Hayes, DJ. (2001). Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer. 85(2): 273-278.
    https://doi.org/10.1054/bjoc.2001.1876
    PMid:11461089 PMCid:PMC2364032

    3. Takano, Т., Ohyama, T., Kokumoto, A., Satoh, R., Hohdatsu, Ts. (2011). Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Research 158, 161-168.
    https://doi.org/10.1016/j.virusres.2011.03.027
    PMid:21473893

    4. Zhao, X., Xian, S., Xiao-li, L. (2012) Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer. Asian Pacific J Cancer Prev. 13, 2873-2877.
    https://doi.org/10.7314/APJCP.2012.13.6.2873
    PMid:22938476

    5. Ghasemi, M., Omid, E., Farshad, N., Ahmadreza, B., Saeid, A., Laleh, V., Moghimpour, R. (2011). Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. Acta Medica Iranica 49(12): 776-779.

    6. Stefanou, D., Anna, B., Sevasti, K., Evdokia, A., Dionysios, J.P., Niki, J.A. (2004). Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18 (2): 155-160.

    7. Campos, A.G., Campos, J. A., Sanches, D. S., Dagli, M. L., Matera, J. M. (2012). Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open Journal of Veterinary Medicine 2, 191-195.
    https://doi.org/10.4236/ojvm.2012.24030

    8. Martano, M., Restucci, B., Ceccarelli, D. M., Muzio, L. L., Maiolino, P. (2016). Immunohistochemical expression of vascular endothelial growth factor in canine oral squamous cell carcinomas. Oncology Letters 11, 399-404.
    https://doi.org/10.3892/ol.2015.3847
    PMid:26870224 PMCid:PMC4727185

    9. Millanta, F., Andreani, G., Rocchigiani, G., Lorenzi, D., Poli, A. (2016). Correlation between cyclo-oxygenase-2 and vascular endothelial growth factor expression in canine and feline squamous cell carcinomas. J Comp Pathol. 154(4): 297-303.
    https://doi.org/10.1016/j.jcpa.2016.02.005
    PMid:27012907

    10. Barrientos, S., Olivera, S., Michael, S.G., Harold, B., Marjana, T. (2008). Growth factors and cytokines in wound healing. Wound Rep Reg. 16, 585-601.
    https://doi.org/10.1111/j.1524-475X.2008.00410.x
    PMid:19128254

    11. Robinson, R.S., Woad, K.J., Hammond, A.J., Laird ,M., Hunter, M.G., Mann, G.E. (2009). Angiogenesis and vascular function in the ovary. Reproduction 138, 869-881.
    https://doi.org/10.1530/REP-09-0283
    PMid:19786399

    12. Sack, U., Hoffmann, M., Zhao, X.J., Chan, K.S., Hui, D.S.C., Gosse, H., Engelmann, L., Schauer, J., Emmrich, F., Hoheisel, G. (2005). Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J. 25, 600-604.
    https://doi.org/10.1183/09031936.05.00037004
    PMid:15802331

    13. Bekes, I., Thomas, W.P.F., Tanja, K., Volker, M., Wolfgang, J., Achim, W., Wulff, C. (2016). Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Molecular Cancer 15, 13.
    https://doi.org/10.1186/s12943-016-0497-3
    PMid:26868378 PMCid:PMC4751711

    14. Sun, X., Dong, W., Gao, L., Jiang, X. (2003). Detection of VEGF levels in ascites and peritoneal fluid. Chinese Journal of Cancer Research 15(4): 310-314.
    https://doi.org/10.1007/BF02974898

    15. Askari, V.R., Vafa, B.R., Parvin, Z., Narges, F., Pouria, R., Amir, H.S., Rakhshandeh, H. (2018). Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats. Biomedicine & Pharmacotherapy 99, 346-353.
    https://doi.org/10.1016/j.biopha.2018.01.068
    PMid:29665643

    16. Clifford, C.A., Dez, H., Matthew, W.B., Carolyn, J.H., Kenneth, J.D., Karin, U.S. (2002). Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Intern Med. 16,164-168.
    https://doi.org/10.1111/j.1939-1676.2002.tb02349.x
    PMid:11899032

    17. Wergin, M.C., Kaser-Hotz, B. (2004). Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 18(1): 15-19.

    18. Kato, Y., Asano, K., Mogi, T., Kutara, K., Teshima, K., Edamura, K. Tsumagari, S., Hasegawa, A., Tanaka, S. (2007). Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J Vet Med Sci. 69(1): 77-80.
    https://doi.org/10.1292/jvms.69.77
    PMid:17283406

    19. Wolfesberger, B., de Arespacohaga, G., Willmann, A., Gerner, M., Miller, W., Schwendenwein, I., et al. (2007). Expression of vascular endothelial growth factor and its receptors in canine lymphoma. Journal of Comparative Pathology 137(1): 30-40.
    https://doi.org/10.1016/j.jcpa.2007.03.003
    PMid:17467003

    20. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D., Gastl, G. (1999). Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila). 85, 178-187.
    https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7

    21. Rudlowski, C., Pickart, A.K., Fuhljahn, C., Friepoertner, T., Schlehe, B., Biesterfeld, S., Schroeder, W. (2006). Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer. 16(1): 183-189.
    https://doi.org/10.1136/ijgc-00009577-200602001-00029
    PMid:16515588

    22. Roskoski, J.R. (2007). Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 62, 179-213.
    https://doi.org/10.1016/j.critrevonc.2007.01.006
    PMid:17324579

    23. Dvorak, H.F. (2002). Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 20(21): 4368-4380.
    https://doi.org/10.1200/JCO.2002.10.088
    PMid:12409337

    24. Queiroga, F.L., Pires, I., Parente, M., Gregório, H., Lopes, C.S. (2011). COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. Vet J. 189(1): 77-82.
    https://doi.org/10.1016/j.tvjl.2010.06.022
    PMid:20675158

     

 
 
Linija

 

 

 

lc
cope This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
crossref
CrosCheck
lc
Creative Commons License
The all content of the Journal "Mac Vet Rev", except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
iThenticate
lc